Get Ready for the Excitement: Iovance Braces for Volatility Ahead of PDUFA Date (NASDAQ:IOVA)
CIPhotos Iovance Biotherapeutics (NASDAQ:IOVA) is preparing for lifileucel’s (LN-144), extended Prescription Drug User Fee Act (PDUFA) goal date of February 24th, 2024, which is the FDA’s…
Read More...
Read More...